Orthocell Ltd (OCC) — Capital Reinvestment Ratio
Latest as of December 2022:
0.03x
Orthocell Ltd (OCC) has a Capital Reinvestment Ratio of 0.03x as of December 2022, meaning it reinvests 0% of its operating cash flow (AU$16.45 Million) in capital expenditures (AU$572.64K). See Orthocell Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.03x
Capex / Operating Cash Flow
Operating Cash Flow
AU$16.45 Million
AUD
Capital Expenditures
AU$572.64K
AUD
Data as of
Dec 2022
Most recent filing
Orthocell Ltd Capital Reinvestment Ratio (2023–2023)
This chart tracks Orthocell Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Orthocell Ltd (2023–2023)
Year-by-year Capital Reinvestment Ratio for Orthocell Ltd from 2023 to 2023. For live market cap and broader valuation context, see Orthocell Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.04x | AU$14.59 Million | AU$631.56K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow